Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Specialst Programme : Aldo-keto reductases (AKRs), BaP Therapgy and drug redeployment strategies for accelerating thraphy development for haematological cancers
Khanim, Farhat
(Co-Investigator)
Drayson, Mark
(Principal Investigator)
Biosciences
Overview
Fingerprint
Research output
(1)
Research output
Research output per year
2021
2021
2021
1
Article
Research output per year
Research output per year
1 results
Title
(ascending)
Publication Year, Title
Title
(descending)
Type
Filter
Article
Search results
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing
Jiang, Y.
,
Southam, A. D.
,
Trova, S.
,
Beke, F.
,
Alhazmi, B.
,
Francis, T.
,
Radotra, A.
,
Di Maio, A.
,
Drayson, M. T.
,
Bunce, C. M.
&
Khanim, F. L.
,
22 Oct 2021
,
In:
British Journal of Cancer.
126
,
2
,
p. 275-286
7 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Valproic Acid
100%
Myeloid Cells
93%
Acute Myeloid Leukemia
87%
Reactive Oxygen Species
73%
Bezafibrate
68%
63
Downloads (Pure)